Health ❯Healthcare

Cardiovascular Disease

Chronic Diseases Cardiovascular Disease Public Health Policy Pharmacology Medical Research Clinical Guidelines HIV Public Health Pharmaceuticals Patient Safety

HHS Panel Recommends Statins for Cardiovascular Prevention in Adults with HIV

Drawing on REPRIEVE trial findings, the new guidelines target adults 40 to 75 with HIV who face low to intermediate ten-year cardiovascular risk.

Obicetrapib Shows Promise in Reducing LDL Cholesterol and Lp(a) in High-Risk Patients